GlassScriptPhysician profile
Peter G Mavrelis
NPI 1326043597
$12,731.11
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $711 · 2021: $153.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11,092.34 | 2019-2021 | |
| Abbvie INC. | $399.63 | 2019-2021 | |
| Gilead Sciences, INC. | $256.39 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $184.15 | 2019-2020 | |
| Endogastric Solutions, INC | $145.07 | 2019-2021 | |
| Pfizer INC. | $85.47 | 2019-2020 | |
| Shionogi INC | $74.70 | 2019-2020 | |
| Allergan, INC. | $67.67 | 2019-2020 | |
| Ucb, INC. | $63.83 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $63.76 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $53.63 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $38.56 | 2019-2020 | |
| Redhill Biopharma INC. | $37.95 | 2020 | |
| Mylan Specialty L.P. | $33.76 | 2019 | |
| Janssen Biotech, INC. | $27.61 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $26.42 | 2019 | |
| Alfasigma USA, INC. | $24.89 | 2020 | |
| Advanced Respiratory, INC | $21.77 | 2019 | |
| Vivus LLC | $18.48 | 2020 | |
| Evoke Pharma, INC. | $15.03 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mavrelis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.